Haemophilus influenzae: Pathogenesis and qPCR Detection Overview

1. Morphology and Structure
This bacterium is pleomorphic, appearing as coccobacilli, short rods, or filamentous forms (approximately 0.3–0.5 μm in length). It lacks spores and motility but possesses pili that enable strong adhesion to respiratory epithelial cells.

Encapsulated strains produce a polysaccharide capsule, which enhances immune evasion and serves as a key basis for serotyping.

2. Growth Requirements
H. influenzae requires both X factor (hemin) and V factor (NAD) for growth.

Chocolate agar is the preferred culture medium, where colonies appear smooth, moist, and gray-white with a diameter of 1–2 mm.

3. Biochemical Characteristics
Based on biochemical reactions such as indole, urease, and ornithine decarboxylase tests, the bacterium is classified into multiple biotypes, with types I–III being most common in clinical isolates.

1. Virulence Factors

• Capsule: Prevents phagocytosis and enhances invasiveness
• Pili: Promote adhesion and biofilm formation
• Endotoxin (LPS): Triggers strong inflammatory responses
• IgA protease: Disrupts mucosal immune defense

2. Clinical Diseases
H. influenzae is associated with a wide spectrum of diseases:

• Meningitis (especially in children)
• Otitis media (major pediatric pathogen)
• Pneumonia and lower respiratory infections
• Secondary infections following viral diseases

Co-infection following influenza or other viral infections significantly increases disease severity.

Protective immunity is mainly mediated by antibodies against capsular polysaccharides, enhancing opsonization and bacterial clearance.

Cell-mediated immunity also contributes through activation of macrophages and NK cells.

However, antigenic variation and structural modification of LPS enable certain strains to evade immune detection, especially in immunocompromised individuals.

1. Microscopy
Gram-negative small rods observed in clinical specimens; sensitivity is moderate (60–70%).

2. Culture and Identification
Growth on chocolate agar under 5–10% CO₂, followed by biochemical and satellite testing for confirmation.

3. Molecular Detection
Real-time qPCR enables rapid detection and strain typing within hours, significantly improving diagnostic efficiency.

4. Serological Tests
Includes capsular swelling tests and latex agglutination for rapid antigen detection.

1. Vaccination
Hib conjugate vaccines provide highly effective protection, reducing incidence of invasive disease by over 90%.

2. Hygiene Practices
Hand hygiene and respiratory etiquette reduce transmission risk.

3. Infection Control
Environmental monitoring and disinfection in healthcare settings are critical.

4. Antibiotic Stewardship
Rational antibiotic use is essential to limit resistance development.